About: A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1996 (uk) im Oktober 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 1996 (ast) scientific article published on 01 October 1996 (en)
publication date	wds:Q71545355-BA0CD7B1-1178-4B17-ACF3-45609288F2D4
publication date	1996-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71545355-6A2B4761-7E6D-4605-8ED9-A625A9B930F3
language of work or name	English
author name string	wds:Q71545355-1EA374B4-B6F0-4530-BB18-E1DF882D1D5F wds:Q71545355-2A189681-1A4A-4ACE-924E-8D97ADF3B036 wds:Q71545355-30331CD4-B3DA-4C65-B755-E13F6AB629C5 wds:Q71545355-6305B04C-9D95-4DC2-8CFE-EE7462C4E176 wds:Q71545355-9111313D-7E9A-4512-8550-40F0FF695D4A wds:Q71545355-A293AB83-13CE-4FB4-825C-17B9B1C199F2 wds:Q71545355-AA6C92C6-F892-418A-907A-CFC4BB6B456E wds:Q71545355-C9E3373C-A631-4B99-AA68-DBD36207362C wds:Q71545355-CD7508FD-4956-426C-83F4-41C45A64DC81 wds:Q71545355-CE6712E5-A729-49FB-BD28-E4A2F6412914 wds:Q71545355-FB9EC299-8719-4925-938E-C2E29477367E
author name string	Hughes MD Lederman MM Merigan TC Katzenstein DA Phair JP Hirsch MS Hammer SM Niu M Henry WK Gundacker H Haubrich RH
rdfs:label	A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (en) A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (nl)
skos:prefLabel	A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (en) A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (nl)
name	A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (en) A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (nl)
author	wds:Q71545355-26838BE5-C33E-4C20-B891-61AA1A81E024
author	Robert T. Schooley
title	wds:Q71545355-732CC274-5B3B-4546-AF76-088501E48AFC
title	A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team (en)
page(s)	wds:Q71545355-BA51C610-1E8C-4403-8A5B-86C5B233D0C9
page(s)	1081-1090
instance of	wds:Q71545355-3BD21E10-68B1-409C-8529-FC624F656482
instance of	scholarly article
main subject	wds:Q71545355-B6664A08-B45D-4D7F-89A9-C111033B5B22
main subject	HIV
PubMed ID	wds:Q71545355-C3EEB882-260F-492C-8A59-AFCB2FC2B60B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8813038
PubMed ID	8813038
published in	wds:Q71545355-65B1C443-5AB0-4E07-81FB-89B55874CD92
published in	The New England Journal of Medicine
issue	wds:Q71545355-19A92D56-F790-43C9-998E-415E3E9905D4
volume	wds:Q71545355-ACA16297-09F0-42A2-B899-37161A225216
issue	15
volume	335
number of pages	wds:Q71545355-F3C11C47-18B1-4BAC-A6F9-97FB9C71CB1F
number of pages	10 (xsd:decimal)
DOI	wds:Q71545355-1C579B2D-8D1A-4382-A550-9C3169C7686B
DOI	http://dx.doi.org/10.1056/NEJM199610103351501
DOI	10.1056/NEJM199610103351501
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71545355
is cites work of	The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses Decline in HIV infectivity following the introduction of highly active antiretroviral therapy The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects. Combination chemotherapy for human immunodeficiency virus-1. The impact of high-risk patients on the results of clinical trials HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Variable selection for optimal treatment decision The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors Attenuated replication of human immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase mutation. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection. Protease inhibitors as antiviral agents. Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus Lamivudine (3TC) phosphorylation and drug interactions in vitro A combinatorial ledge: reverse transcriptase fidelity, total body viral burden, and the implications of multiple-drug HIV therapy for the evolution of antiviral resistance Guidelines for antiretroviral therapy for HIV infection. Canadian HIV Trials Network Antiretroviral Working Group. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir Adverse effects of antiretroviral therapy Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine Semiparametric Estimation of Treatment Effect in a Pretest-Posttest Study with Missing Data Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes Antiretroviral therapy for human immunodeficiency virus infection in 1997. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software